Related Articles
Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma
Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer
Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy
Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma
Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β‑catenin signaling pathway